Intuitive Surgical, Inc.
MX ˙ BMV ˙ US46120E6023
SecurityMX:ISRG / Intuitive Surgical, Inc.
InstitutionScotia Capital Inc.
Latest Disclosed Ownership5,080 shares
Latest Disclosed Value $ 2,341,923
Scotia Capital Inc. reports 11.47% decrease in ownership of ISRG / Intuitive Surgical, Inc.

On May 13, 2026 - Scotia Capital Inc. filed a 13F-HR form disclosing ownership of 5,080 shares of Intuitive Surgical, Inc. (MX:ISRG) valued at $2,341,923 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 5,738 shares of Intuitive Surgical, Inc.. This represents a change in shares of -11.47% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F INTUITIVE SURGICAL COM NEW 46120E602 5,080 -658 -11.47 2,342 -27.90 0.0096
2026-02-12 2025-12-31 13F INTUITIVE SURGICAL COM NEW 46120E602 5,738 53 0.93 3,247 27.73 0.0131
2025-11-14 2025-09-30 13F INTUITIVE SURGICAL COM NEW 46120E602 5,685 -305 -5.09 2,543 -21.86 0.0108
2025-08-13 2025-06-30 13F INTUITIVE SURGICAL COM NEW 46120E602 5,990 739 14.07 3,254 25.12 0.0154
2025-05-09 2025-03-31 13F INTUITIVE SURGICAL COM NEW 46120E602 5,251 85 1.65 2,601 -3.60 0.0139
2025-02-13 2024-12-31 13F INTUITIVE SURGICAL COM NEW 46120E602 5,166 204 4.11 2,697 10.67 0.0142
2024-11-13 2024-09-30 13F INTUITIVE SURGICAL COM NEW 46120E602 4,962 44 0.89 2,438 11.43 0.0131
2024-08-14 2024-06-30 13F INTUITIVE SURGICAL COM NEW 46120E602 4,918 2,324 89.59 2,188 111.30 0.0128
2024-05-14 2024-03-31 13F INTUITIVE SURGICAL COM NEW 46120E602 2,594 72 2.85 1,035 21.76 0.0062
2024-02-12 2023-12-31 13F INTUITIVE SURGICAL COM NEW 46120E602 2,522 -350 -12.19 851 1.31 0.0055
2023-11-14 2023-09-30 13F INTUITIVE SURGICAL COM NEW 46120E602 2,872 -367 -11.33 839 -24.21 0.0061
2023-08-03 2023-06-30 13F INTUITIVE SURGICAL COM NEW 46120E602 3,239 550 20.45 1,108 61.37 0.0076
2023-05-11 2023-03-31 13F INTUITIVE SURGICAL COM NEW 46120E602 2,689 -337 -11.14 687 -14.46 0.0050
2023-02-09 2022-12-31 13F INTUITIVE SURGICAL COM NEW 46120E602 3,026 -391 -11.44 803 25.31 0.0062
2022-11-10 2022-09-30 13F INTUITIVE SURGICAL COM NEW 46120E602 3,417 -17,264 -83.48 640 -84.58 0.0052
2022-08-05 2022-06-30 13F INTUITIVE SURGICAL COM NEW 46120E602 20,681 -3,473 -14.38 4,151 -43.04 0.0309
2022-05-09 2022-03-31 13F INTUITIVE SURGICAL COM NEW 46120E602 24,154 820 3.51 7,287 -13.08 0.0461
2022-02-11 2021-12-31 13F INTUITIVE SURGICAL COM NEW 46120E602 23,334 14,570 166.25 8,384 -3.78 0.0550
2021-11-12 2021-09-30 13F INTUITIVE SURGICAL COM NEW 46120E602 8,764 1,468 20.12 8,713 29.85 0.0634
2021-08-12 2021-06-30 13F INTUITIVE SURGICAL COM NEW 46120E602 7,296 -2,867 -28.21 6,710 -10.65 0.0491
2021-05-06 2021-03-31 13F INTUITIVE SURGICAL COM NEW 46120E602 10,163 561 5.84 7,510 -4.39 0.0609
2021-02-11 2020-12-31 13F INTUITIVE SURGICAL COM NEW 46120E602 9,602 489 5.37 7,855 21.48 0.0722
2020-11-12 2020-09-30 13F INTUITIVE SURGICAL COM NEW 46120E602 9,113 1,852 25.51 6,466 56.26 0.0700
2020-08-11 2020-06-30 13F INTUITIVE SURGICAL COM NEW 46120E602 7,261 -632 -8.01 4,138 5.86 0.0579
2020-05-15 2020-03-31 13F INTUITIVE SURGICAL COM NEW 46120E602 7,893 5,846 285.59 3,909 223.06 0.0545
2020-02-13 2019-12-31 13F INTUITIVE SURGICAL COM NEW 46120E602 2,047 37 1.84 1,210 11.52 0.0135
2019-11-14 2019-09-30 13F INTUITIVE SURGICAL COM NEW 46120E602 2,010 64 3.29 1,085 6.27 0.0128
2019-08-13 2019-06-30 13F INTUITIVE SURGICAL COM NEW 46120E602 1,946 164 9.20 1,021 0.39 0.0124
2019-05-15 2019-03-31 13F INTUITIVE SURGICAL COM NEW 46120E602 1,782 498 38.79 1,017 65.37 0.0131
2019-02-11 2018-12-31 13F/A-1 INTUITIVE SURGICAL COM NEW 46120E602 1,284 322 33.47 615 11.41 0.0091
2019-02-11 2018-12-31 13F INTUITIVE SURGICAL COM NEW 46120E602 962 552
2018-11-14 2018-09-30 13F INTUITIVE SURGICAL COM NEW 46120E602 962 385 66.72 552 131.93 0.0070
2018-08-13 2018-06-30 13F INTUITIVE SURGICAL COM NEW 46120E602 577 0 0.00 238 0.00 0.0033
2018-05-15 2018-03-31 13F INTUITIVE SURGICAL COM NEW 46120E602 577 -21 -3.51 238 9.17 0.0033
2018-02-13 2017-12-31 13F INTUITIVE SURGICAL COM NEW 46120E602 598 598 218 0.0029
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.